tradingkey.logo

Myomo Inc

MYO
0.863USD
+0.022+2.67%
Cierre 11/05, 16:00ETCotizaciones retrasadas 15 min
32.60MCap. mercado
PérdidaP/E TTM

Más Datos de Myomo Inc Compañía

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.

Información de Myomo Inc

Símbolo de cotizaciónMYO
Nombre de la empresaMyomo Inc
Fecha de salida a bolsaJun 12, 2017
Director ejecutivoMr. Paul R. Gudonis
Número de empleados184
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 12
Dirección137 Portland Street
CiudadBOSTON
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal02114
Teléfono16179969058
Sitio Webhttps://myomo.com/
Símbolo de cotizaciónMYO
Fecha de salida a bolsaJun 12, 2017
Director ejecutivoMr. Paul R. Gudonis

Ejecutivos de Myomo Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.25M
-0.79%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
474.42K
+26.71%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
427.90K
+11.59%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
140.62K
+45.75%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
41.75K
+246.97%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--
Mr. Micah J. Mitchell
Mr. Micah J. Mitchell
Chief Commercial Officer
Chief Commercial Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.25M
-0.79%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
474.42K
+26.71%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
427.90K
+11.59%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
140.62K
+45.75%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
41.75K
+246.97%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
Por negocioUSD
Nombre
Ganancia
Proporción
Direct to patient
7.42M
76.88%
Clinical/Medical providers
2.23M
23.12%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Direct to patient
7.42M
76.88%
Clinical/Medical providers
2.23M
23.12%

Estadísticas de accionistas

Actualizado: sáb., 1 de nov
Actualizado: sáb., 1 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Rosalind Advisors, Inc.
9.51%
Herr Investment Group LLC
7.53%
Triple Gate Capital, LP
7.47%
BlackRock Institutional Trust Company, N.A.
4.00%
The Vanguard Group, Inc.
3.94%
Otro
67.55%
Accionistas
Accionistas
Proporción
Rosalind Advisors, Inc.
9.51%
Herr Investment Group LLC
7.53%
Triple Gate Capital, LP
7.47%
BlackRock Institutional Trust Company, N.A.
4.00%
The Vanguard Group, Inc.
3.94%
Otro
67.55%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
22.96%
Investment Advisor
22.00%
Investment Advisor/Hedge Fund
10.68%
Individual Investor
7.42%
Research Firm
2.77%
Venture Capital
0.16%
Pension Fund
0.16%
Bank and Trust
0.09%
Otro
33.75%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
153
22.25M
58.86%
-1.76M
2025Q2
131
25.59M
71.13%
+1.42M
2025Q1
128
23.88M
66.62%
+977.96K
2024Q4
112
23.29M
69.71%
+5.81M
2024Q3
85
19.54M
71.85%
+1.13M
2024Q2
79
18.43M
69.76%
+448.58K
2024Q1
77
16.43M
64.97%
-1.27M
2023Q4
72
14.80M
62.04%
-346.58K
2023Q3
64
15.22M
79.76%
+6.49M
2023Q2
62
8.10M
62.40%
+2.44M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Rosalind Advisors, Inc.
3.60M
9.51%
+892.13K
+33.00%
Jun 30, 2025
Herr Investment Group LLC
2.85M
7.53%
+1.20M
+72.93%
Jun 30, 2024
Triple Gate Capital, LP
2.83M
7.47%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.51M
4%
+1.40M
+1213.08%
Jun 30, 2025
The Vanguard Group, Inc.
1.49M
3.94%
+226.35K
+17.94%
Jun 30, 2025
Gudonis (Paul R)
1.25M
3.3%
-10.00K
-0.79%
Sep 09, 2025
Journey Advisory Group, LLC
875.84K
2.32%
-248.95K
-22.13%
Jun 30, 2025
Worth Venture Partners, LLC
875.76K
2.32%
-312.69K
-26.31%
Jun 30, 2025
Soleus Capital Management, L.P.
704.27K
1.86%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
669.28K
1.77%
+412.63K
+160.78%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Micro-Cap ETF
Proporción0.01%
ProShares Hedge Replication ETF
Proporción0%
iShares Russell 2000 ETF
Proporción0%
iShares Russell 2000 Growth ETF
Proporción0%
Global X Russell 2000 ETF
Proporción0%
Proshares Ultra Russell 2000
Proporción0%
ProShares UltraPro Russell2000
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI